Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 15, 2020 - Issue
Submit an article Journal homepage
109
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Relationship Between Changes in Inhalation Treatment Level and Exacerbation of Chronic Obstructive Pulmonary Disease: Nationwide the Health Insurance and Assessment Service Database

Yong Suk Jo1 Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Hallym University Kangdong Sacred Heart Hospital, Seoul, Korea;2 Lung Research Institute of Hallym University College of Medicine, Chuncheon, South KoreaORCID Iconhttps://orcid.org/0000-0002-6422-6530
ORCID Icon,
Kwang Ha Yoo3 Department of Internal Medicine, Division of Pulmonary and Allergy Medicine, Konkuk University School of Medicine, Seoul, Republic of KoreaORCID Iconhttps://orcid.org/0000-0001-9969-2657
ORCID Icon,
Yong Bum Park1 Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Hallym University Kangdong Sacred Heart Hospital, Seoul, Korea;2 Lung Research Institute of Hallym University College of Medicine, Chuncheon, South KoreaORCID Iconhttps://orcid.org/0000-0002-5814-6104
ORCID Icon,
Chin Kook Rhee4 Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Seoul St Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of KoreaORCID Iconhttps://orcid.org/0000-0003-4533-7937
ORCID Icon,
Ki Suck Jung2 Lung Research Institute of Hallym University College of Medicine, Chuncheon, South Korea;5 Department of Pulmonary, Allergy and Critical Care Medicine, Hallym University Sacred Heart Hospital, Anyang, Republic of Korea
,
Seung Hun Jang2 Lung Research Institute of Hallym University College of Medicine, Chuncheon, South Korea;5 Department of Pulmonary, Allergy and Critical Care Medicine, Hallym University Sacred Heart Hospital, Anyang, Republic of KoreaORCID Iconhttps://orcid.org/0000-0001-5457-5780
ORCID Icon,
Ji Young Park2 Lung Research Institute of Hallym University College of Medicine, Chuncheon, South Korea;5 Department of Pulmonary, Allergy and Critical Care Medicine, Hallym University Sacred Heart Hospital, Anyang, Republic of KoreaORCID Iconhttps://orcid.org/0000-0002-6533-4656
ORCID Icon,
Youlim Kim2 Lung Research Institute of Hallym University College of Medicine, Chuncheon, South Korea;6 Department of Pulmonary, Allergy and Critical Care Medicine, Hallym University Chuncheon Sacred Heart Hospital, Chuncheon-Si, Gangwon-Do, KoreaORCID Iconhttps://orcid.org/0000-0002-1051-0667
ORCID Icon,
Bo Yeon Kim7 Health Insurance Review & Assessment Service, Wonju, Republic of Korea
,
Sang In Ahn7 Health Insurance Review & Assessment Service, Wonju, Republic of Korea
,
Yon U Jo7 Health Insurance Review & Assessment Service, Wonju, Republic of Korea
&
Yong Il Hwang2 Lung Research Institute of Hallym University College of Medicine, Chuncheon, South Korea;5 Department of Pulmonary, Allergy and Critical Care Medicine, Hallym University Sacred Heart Hospital, Anyang, Republic of KoreaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-3502-5211
ORCID Icon show all
Pages 1367-1375 | Published online: 12 Jun 2020

References

  • MathersCD, LoncarD, SametJ. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442. doi:10.1371/journal.pmed.003044217132052
  • HalbertRJ, NatoliJL, GanoA, BadamgaravE, BuistAS, ManninoDM. Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006;28(3):523–532. doi:10.1183/09031936.06.0012460516611654
  • Korean Statistical Information Service (KOSIS). 2016 Available from: http://kosis.kr/eng/. Accessed 81, 2019.
  • CavaillesA, Brinchault-RabinG, DixmierA, et al. Comorbidities of COPD. Eur Respir Rev. 2013;22(130):454–475. doi:10.1183/09059180.0000861224293462
  • ManninoDM, BuistAS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370(9589):765–773. doi:10.1016/S0140-6736(07)61380-417765526
  • LeeJ, LeeJH, KimJA, RheeCK. Trend of cost and utilization of COPD medication in Korea. Int J Chron Obstruct Pulmon Dis. 2017;12:27–33. doi:10.2147/COPD.S12168728031708
  • FusoL, MoresN, ValenteS, MalerbaM, MontuschiP. Long-acting beta-agonists and their association with inhaled corticosteroids in COPD. Curr Med Chem. 2013;20(12):1477–1495. doi:10.2174/092986731132012000323409722
  • MontuschiP, MacagnoF, ValenteS, FusoL. Inhaled muscarinic acetylcholine receptor antagonists for treatment of COPD. Curr Med Chem. 2013;20(12):1464–1476. doi:10.2174/092986731132012000222963553
  • OECD. Health statistics; 2017 Available from: http://www.oecd.org/els/health-systems/health-data.htm/. Accessed 720, 2019.
  • KimDS. Introduction: health of the health care system in Korea. Soc Work Public Health. 2010;25(2):127–141. doi:10.1080/1937191090307033320391257
  • Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease; 2019 Available from: http://www.goldcopd.org/. Accessed 215, 2019.
  • MontuschiP, MalerbaM, MacisG, MoresN, SantiniG. Triple inhaled therapy for chronic obstructive pulmonary disease. Drug Discov Today. 2016;21(11):1820–1827. doi:10.1016/j.drudis.2016.07.00927452453
  • ParkYB, RheeCK, YoonHK, et al. Revised (2018) COPD clinical practice guideline of the Korean Academy of Tuberculosis and Respiratory Disease: a summary. Tuberc Respir Dis (Seoul). 2018;81(4):261–273. doi:10.4046/trd.2018.002929926554
  • Steurer-SteyC, DallalanaK, JungiM, RosemannT. Management of chronic obstructive pulmonary disease in Swiss primary care: room for improvement. Qual Prim Care. 2012;20(5):365–373.23114004
  • AaronSD, VandemheenKL, FergussonD, et al. Tiotropium in combination with placebo, salmeterol, or fluticasone–salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med. 2007;146(8):545–555. doi:10.7326/0003-4819-146-8-200704170-0015217310045
  • WedzichaJA, DecramerM, FickerJH, et al. Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study. Lancet Respir Med. 2013;1(3):199–209. doi:10.1016/S2213-2600(13)70052-324429126
  • CalverleyPMA, AnzuetoAR, CarterK, et al. Tiotropium and olodaterol in the prevention of chronic obstructive pulmonary disease exacerbations (DYNAGITO): a double-blind, randomised, parallel-group, active-controlled trial. Lancet Respir Med. 2018;6(5):337–344. doi:10.1016/S2213-2600(18)30102-429605624
  • KimJ, RheeCK, YooKH, et al. The health care burden of high grade chronic obstructive pulmonary disease in Korea: analysis of the Korean health insurance review and assessment service data. Int J Chron Obstruct Pulmon Dis. 2013;8:561–568. doi:10.2147/COPD.S4857724277985
  • KimJ, KimK, KimY, et al. The association between inhaled long-acting bronchodilators and less in-hospital care in newly-diagnosed COPD patients. Respir Med. 2014;108(1):153–161. doi:10.1016/j.rmed.2013.08.00323993445
  • RheeCK, YoonHK, YooKH, et al. Medical utilization and cost in patients with overlap syndrome of chronic obstructive pulmonary disease and asthma. Copd. 2014;11(2):163–170. doi:10.3109/15412555.2013.83106124111662

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.